An official website of the United States government
September 29, 2026 Edition
News
Antiviral drug did not improve Long COVID symptoms
A clinical trial for Long COVID found that treating patients with a common antiviral drug for up to 25 days did not improve symptoms.
News
tRNA treatment may help restore cystic fibrosis proteins
Lipid nanoparticles delivering engineered transfer RNA restored functional proteins in cell and animal models of cystic fibrosis.
News
Bacterial infection may alter developing gut
C. difficile bacteria caused lasting changes to cells in the intestines of newborn mice.
Displaying 610 - 616 of 912
Blood tests show promise for early Alzheimer's diagnosis
Blood levels of a protein called ptau217 were associated with damage to the brain caused by Alzheimer's disease, and may one day help diagnose disease before symptoms appear.
Screening drug additives for biological activity
A computational screen of more than 600 compounds listed as FDA-approved inactive ingredients found some that may warrant follow-up studies for previously unknown effects.
Potent neutralizing antibodies target new regions of coronavirus spike
Researchers identified some of the most potent and diverse antibodies discovered to date that neutralize SARS-CoV-2, targeting multiple regions on the viral spike.
High blood sugar may blunt benefits of aerobic exercise
Mice with high blood sugar levels had lower gains from aerobic exercise than normal mice. The results suggest that diet changes may be needed to get the most from aerobic exercise.
What goosebumps are for
Researchers discovered a new role for goosebumps that could have implications for reversing hair loss and understanding wound healing in the skin.
Approach to prevent fall injuries no better than usual care
In a large study, individualized plans designed to prevent serious injuries from falls among older adults who are at high risk didn’t improve upon usual care.
Sex differences in brain anatomy
An analysis of more than 2,000 brain scans showed sex differences in the volume of certain regions in the human brain that may contribute to differences in brain disease and behavior.